Date of Annual General Meeting – 25 November 2026
Sydney, Australia 21 September 2026 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce, in accordance with Listing Rule 3.13.1, that the date of its AGM will be 25 November 2026. In accordance with…